Pharmafile Logo
Pharmafocus logo
Advanced Search

Japan

Showing 15 posts of 81 posts found.

Eisai image

Eisai seeks new ALS drug approval

May 28, 2015
Sales and Marketing Eisai, Japan, als, mecobalamin

Eisai is hoping that existing neurology drug mecobalamin can be a new option for the difficult-to-treat condition amyotrophic lateral sclerosis …

News
Abbvie image

AbbVie hep C drug gets priority review in Japan

April 16, 2015
Sales and Marketing AbbVie, EC, EU, Europe, Exviera, FDA, Japan, Viekira Pak, Viekirax, hepatitis C, ombitasvir/paritaprevir/ritonavir

AbbVie’s combination hepatitis C treatment looks set to be approved in yet another country after being granted priority review in …

News
Bayer image

Bayer and Regeneron eye drug gains another indication

March 26, 2015
Sales and Marketing Bayer, Eylea, FDA, Japan, Lucentis, MRI, Regeneron, aflibercept

Bayer and Regeneron’s Eylea has added to a growing list of indications with its new approval to treat a type …

News
Eisai image

Eisai launches Lenvima in US

March 2, 2015
Sales and Marketing FDA, Japan, Lenvima, US, dtc, thyroid

Japanese firm Eisai has launched its new thyroid cancer offering Lenvima in the US, making it the first country in …

News
Takeda image

Takeda trial hits late-stage buffers

February 17, 2015
Research and Development, Sales and Marketing AMG 706, Japan, NSCLC, Takeda, lung cancer, motesanib

Takeda is to scrap an advanced trial of an investigational drug after it failed to show any benefit in survival …

News

UK lags behind in healthcare outcomes index

November 26, 2014
Research and Development, Sales and Marketing Japan, NHS, UK, WHO, economist, health outcomes

Whilst healthcare outcomes in the UK arguably remain among the best in the world according to recent findings by The …

News
Takeda image

GE and Takeda make liver pact

November 13, 2014
Research and Development, Sales and Marketing GE Healthcare, Japan, Takeda, US, liver, nafld, nash

GE Healthcare and Takeda Pharmaceutical have joined forces to develop treatments which target liver conditions including non-alcoholic fatty liver disease …

News
novartis image

Novartis faces data fraud charges in Japan

July 3, 2014
Medical Communications, Sales and Marketing Diovan, Japan, Novartis, data, fraud, heart, valsartan

Novartis is facing criminal charges in Japan over the alleged falsifying of data for its once big-selling heart drug Diovan. …

News
Toshiba image

Toshiba creates disease diagnosis tool

May 13, 2014
Medical Communications, Research and Development, Sales and Marketing Disease, Japan, breath analyser, toshiba

Japan’s multinational electronics firm Toshiba has developed a breath-analysing prototype system that it says can be used to diagnose diseases.  …

News

Police raid Novartis Tokyo office

February 20, 2014
Medical Communications, Sales and Marketing Diovan, Japan, Novartis, tokyo

Authorities in Japan have raided the premises of Novartis’ Tokyo operation as part of an ongoing investigation into the promotion …

News
Novartis image

Novartis faces Japan probe

January 10, 2014
Sales and Marketing Diovan, Japan, Novartis

Novartis is under pressure in Japan where authorities are looking at the way the Swiss firm promoted its blood pressure …

News
eisai image

Eisai signs tropical disease deal

November 12, 2013
Research and Development, Sales and Marketing Disease, Eisai, Japan, broad, ntd, tropical

Eisai has become the latest pharma firm to partner with the US-based Broad Institute to pool expertise and come up …

News
Diovan image

Novartis ‘sorry’ for Diovan data

September 27, 2013
Sales and Marketing Japan, Novartis, diovan data

Novartis has apologised to patients in Japan over the alleged manipulation of data in five trials of its blockbuster blood …

News
iphone_4

AZ/Daiichi Sankyo create Japan iPhone app for acid reflux

September 19, 2013
Medical Communications, Sales and Marketing AstraZeneca, Daiichi Sankyo, Japan, Nexium, app, iphone

News
Eisai image

Eisai backs disease fund

July 12, 2013
Research and Development, Sales and Marketing Eisai, Japan, TB, partnership

A leading Japanese pharma group says that the sector should see investment in fighting diseases of the developing world as …

News

Latest content

Eisai and Biogen’s Leqembi launched for Alzheimer’s treatment in China

June 28, 2024

AbbVie’s Tepkinly gains positive CHMP opinion for follicular lymphoma treatment

June 28, 2024

IDEAYA Biosciences announces first-patient-in for phase 1 clinical trial evaluating IDE397 and Trodelvy combination in MTAP-deletion bladder cancer

June 27, 2024

Immunotherapy created at Roswell Park Comprehensive Cancer Center given expanded ODD by FDA

June 27, 2024

Abcuro completes enrolment for phase 2/3 IBM treatment trial

June 26, 2024